340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

CMS Wants to Ramp up Medicaid Rebate Oversight

Closer monitoring of manufacturer compliance could have 340B implications 

March 18, 2014—The Obama administration proposes to audit and survey drugmakers more often to ensure they are fulfilling their Medicaid drug rebate obligations and to increase penalties for those that knowingly report false information for the calculation of rebates. … [Read more...]

340B Savings Critical for Ore. Health Centers, Study Concludes

Says mandated pass-through to MCOs could reduce access to medicines, services 

March 12, 2014—Requiring Oregon health centers to give the state all of their 340B savings on drugs for Medicaid beneficiaries, whose care is mainly managed and paid for by the state's new Medicaid coordinated care organizations, "may not actually be effective and could adversely impact patient care," a new study concludes. … [Read more...]

HRSA to Issue Three More 340B Regulations

Rules will create dispute resolution system and establish sanctions for manufacturers and providers 

March 6, 2014—While attention has focused on the forthcoming comprehensive regulation for the 340B program, aka the "mega-reg," the Health Resources and Services Administration is moving ahead with three other significant program regulations. … [Read more...]

HRSA Sketches out Its Priorities for 340B Funding

Verification of ceiling prices emerges as an area of focus 

March 5, 2014—Details about the Health Resources and Services Administration's (HRSA) policy priorities for the 340B program this fiscal year and next have emerged in a drug industry newsletter and in a supplement to President Obama's budget request to Congress. … [Read more...]

White House Seeks $17 Million for 340B Program

$7 million would come from user fee on purchases 

March 4, 2014—The Obama administration is seeking $17 million for the 340B drug discount program in fiscal 2015, consisting of $10 million in appropriated funds and $7 million from a 0.1 percent user fee on 340B drug purchases. … [Read more...]

CMS OK’s California’s 340B Medicaid Carve-Out Ban and AAC Billing Requirement

Lawsuit over the policy is now before a federal appeals court 

February 28, 2014—The federal Centers for Medicare and Medicaid Services (CMS) has approved California Medicaid's 2009 policy requiring 340B covered entities to "carve in" their Medicaid purchases and to pass their 340B discounts on to Medicaid by billing such drugs at no more than actual acquisition cost (AAC) plus a dispensing fee. … [Read more...]

That Takes Chutzpah

 

We’ve noticed that Eli Lilly and Co. has been taking pot shots at the 340B program calling for more oversight and transparency. This from a company that agreed to plead guilty and pay $1.4 billion for promoting its antipsychotic drug Zyprexa for uses not approved by the Food and Drug Administration including marketing it to elderly patients with dementia. Health care providers … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health